[1] |
SANTAMARIA PG, MORENO-BUENO G, PORTILLO F, et al.EMT:Present and future in clinical oncology[J].Mol Oncol, 2017, 11(7):718. doi: 10.1002/1878-0261.12091 |
[2] |
PÉREZ-SALA D, OESTE CL, MARTÍNEZ AE, et al.Vimentin filament organization and stress sensing depend on its single cysteine residue and zinc binding[J].Nat Commun, 2015, 6:7287. doi: 10.1038/ncomms8287 |
[3] |
LIU XL, ZHANG XT, MENG J, et al.ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways[J].Oncotarget, 2017, 8(33):54265. |
[4] |
TIWARI R, PANDEY SK, GOEL S, et al.SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression[J].Oncogenesis, 2015, 4(8):e162. doi: 10.1038/oncsis.2015.23 |
[5] |
OHMURAYA M, SUGANO A, HIROTA M, et al.Role of intrapancreatic SPINK1/Spink3 expression in the development of pancreatitis[J].Front Physiol, 2012, 3(4):126. |
[6] |
STENMAN UH.Role of the tumor-associated trypsin inhibitor SPINK1 in cancer development[J].Asian J Androl, 2011, 13(4):628. doi: 10.1038/aja.2011.45 |
[7] |
CHANG MC, WU CH, YANG SH, et al.Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan[J].Am J Cancer Res, 2017, 7(2):357. |
[8] |
MEHNER C, OBERG AL, KIMBERLY R, et al.Serine protease inhibitor Kazal type 1(SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers[J].Oncotarget, 2015, 6(34):35737. |
[9] |
ZHANG XM, YIN XX, SHEN PF, et al.The association between SPINK1and clinical outcomes in patients with prostate cancer; a systematic review and meta-analysis[J].Onco Targets Ther, 2017, 10(7):3123. |
[10] |
DMELLO C, SAWANT S, ALAM H, et al.Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients[J].PLoS One, 2017, 12(2):e0172559. doi: 10.1371/journal.pone.0172559 |
[11] |
LIN JY, LU JQ, WANG C, et al.The prognostic values of the expression of Vimentin, TP53, and Podoplanin in patients with cervical cancer[J].Cancer Cell Int, 2017, 17(9):80. |
[12] |
LIU LG, YAN XB, XIE RT, et al.Stromal expression of Vimentin predicts the clinical outcome of stage Ⅱ colorectal cancer for high-risk patients[J].Med Sci Monit, 2017, 23(7):2897. |